Patents Examined by N. Harkaway
  • Patent number: 4374996
    Abstract: A process for preparing cimetidine by sulfur extrusion from N-cyano-N'-methyl-N"-[2-(5-methyl-4-imidazolylmethyldithio)ethyl]guanidine .
    Type: Grant
    Filed: June 3, 1981
    Date of Patent: February 22, 1983
    Assignee: SK & F Lab Co.
    Inventors: Clifford S. Labaw, George R. Wellman
  • Patent number: 4371540
    Abstract: Two compounds represented by the formula ##STR1## wherein R is hydrogen or a 2-hydroxyethyl radical are reported to have minimum penetration into the brain and nerve tissues combined with maximum penetration into hypoxic tumor cells. This combination of properties makes these compounds the optimal radiosensitizers among electron-affinic 1-substituted 2-nitroinidazoles.
    Type: Grant
    Filed: August 22, 1980
    Date of Patent: February 1, 1983
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: William W. Lee, J. Martin Brown, Abelardo P. Martinez, Michael J. Cory
  • Patent number: 4369183
    Abstract: The invention concerns novel 2-aryl-1,2-benzisothiazolinone-1,1-dioxide compounds; methods for their preparation; pharmaceutical compositions containing them as an active ingredient; and methods of selectively inhibiting proteases, especially elastase, and of treating emphysema, rheumatoid arthritis, and various inflammatory diseases, for example, bronchial inflammation.
    Type: Grant
    Filed: February 2, 1981
    Date of Patent: January 18, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Howard Jones, Robert L. Clark, Morris Zimmerman
  • Patent number: 4367235
    Abstract: 2-benzimidazolinone compounds of the formula ##STR1## wherein R is lower alkyl,R.sub.1 and R.sub.2, which can be the same or different, are lower straight-chained or branched alkyl and one of R.sub.1 and R.sub.2 can also be hydrogen orR.sub.1 and R.sub.2 together represent an alkylene radical and R.sub.3 is hydrogen or acyl, i.e., alkanoyl or aromatic carboxylic acid moieties;and the pharmacologically acceptable salts thereof; have marked .beta.-receptor blocking action and are outstandingly useful in the treatment or prophylaxis of cardiac and circulatory diseases.
    Type: Grant
    Filed: July 18, 1980
    Date of Patent: January 4, 1983
    Assignee: Boehringer Mannheim GmbH
    Inventors: Carl H. Ross, Walter-Gunar Friebe, Wolfgang Kampe, Wolfgang Bartsch, Egon Roesch
  • Patent number: 4360679
    Abstract: Novel benzofuranyl benzimidazoles of the formula ##STR1## wherein R.sub.1 represents a hydrogen atom, an alkenyloxy or cycloalkyloxy radical, an unsubstituted or substituted alkoxy, phenylalkoxy or phenoxy radical,each ofR.sub.2 and R.sub.3 independently represents a hydrogen atom, an alkyl or alkoxy radical, a halogen atom, or, if R.sub.1 represents hydrogen, together in the ortho-position to each other they represent a radical of the formula --CH.dbd.CH--CH.dbd.CH--, --O--CH.sub.2 --O-- or --O--CH.sub.2 --CH.sub.2 --O--,R.sub.4 represents a hydrogen atom, an alkyl, alkoxy or phenyl radical,R.sub.5 represents a sulpho or carboxyl group or the functional derivatives thereof including the cyano group or the trifluoromethyl group,R.sub.6 represents a hydrogen or halogen atom, an alkyl or alkoxy radical,R.sub.7 represents a cycloalkyl, alkenyl, or unsubstituted or substituted alkyl, phenyl or phenylalkyl radical, or, if n is 0, also represents a hydrogen atom,R.sub.
    Type: Grant
    Filed: September 30, 1980
    Date of Patent: November 23, 1982
    Assignee: Ciba-Geigy Corporation
    Inventors: Hans R. Meyer, Kurt Weber
  • Patent number: 4360680
    Abstract: A method of treating pain, meliorating inflammation in warm-blooded animals as well as a method for treating fungal and bacterial infections in such animals using certain 3-amino-1-phenyl-2-pyrazolines and 3-amino-1-substituted phenyl-2-pyrazolines and their C4 and C5 analogs, as well as compounds used in the above are disclosed.
    Type: Grant
    Filed: July 13, 1981
    Date of Patent: November 23, 1982
    Assignee: American Cyanamid Company
    Inventors: John P. Dusza, Joseph P. Joseph, Seymour Bernstein
  • Patent number: 4358599
    Abstract: 4-Nitro-1,2-hydrocarbyl pyrazolidines are prepared by a novel route from 1,2-disubstituted hydrazines and 1,3-di-(secondary amino)-2-nitropropanes and reduced to the corresponding 4-amino-1,2-hydrocarbyl pyrazolidines, which latter compounds are intermediates in the preparation of certain pharmaceutical benzamides.The novel 4-nitro-1,2-hydrocarbyl pyrazolidines have the formula: ##STR1## wherein R.sup.1 and R.sup.2 are selected from loweralkyl, lowercycloalkyl or phenyl-loweralkyl and may be the same or different.
    Type: Grant
    Filed: June 11, 1981
    Date of Patent: November 9, 1982
    Assignee: A. H. Robins Company, Inc.
    Inventors: Young S. Lo, Harry R. Munson, Jr.
  • Patent number: 4357339
    Abstract: 1,5-Dimethyl-6,7-dioxabicyclo[3.2.1]-octane and 1,5-dimethyl-6,7-diazabicyclo[3.2.1]-oct-6-ene are synthesized. They are analogs of the western and southern pine beetle natural-pheromone, frontalin. They are useful for controlling the multiplication of these harmful insects and for limiting infestation of wooded areas by them.
    Type: Grant
    Filed: December 22, 1980
    Date of Patent: November 2, 1982
    Assignee: Research Corporation
    Inventors: R. Marshall Wilson, John W. Rekers
  • Patent number: 4355035
    Abstract: Derivatives of certain pyridyliminomethylbenzenes, useful as fungicides.
    Type: Grant
    Filed: January 26, 1981
    Date of Patent: October 19, 1982
    Assignee: Shell Oil Company
    Inventors: Pieter Ten Haken, Shirley B. Webb
  • Patent number: 4354031
    Abstract: New and valuable pyrazole derivatives having a good herbicidal action, herbicides containing these compounds as active ingredients, and processes for controlling the growth of unwanted plants with these compounds.
    Type: Grant
    Filed: August 25, 1980
    Date of Patent: October 12, 1982
    Assignee: BASF Atiengesellschaft
    Inventors: Peter Plath, Bruno Wuerzer, Wolfgang Rohr
  • Patent number: 4353921
    Abstract: Novel 1,2-disubstituted imidazol(in)es are described herein. The compounds are generally produced by reacting a haloacylanilide with an excess of 2-substituted-imidazol(in)e. The compounds are antiarrhythmic agents.
    Type: Grant
    Filed: June 19, 1981
    Date of Patent: October 12, 1982
    Assignee: Berlex Laboratories, Inc.
    Inventors: Julius Diamond, Thomas K. Morgan, Jr., Ronald A. Wohl
  • Patent number: 4352813
    Abstract: A new salt of [(1-benzyl-1H-indazol-3-yl)oxy] acetic acid (or bendazac) with L. lysine.Following oral administrations of this compound in man, the concentrations of bendazac found in the blood are higher than those obtained after administration of bendazac as such.This discovery extends the therapeutic use of bendazac. In fact, whereas up to now bendazac could only be used topically, the L. lysine salt of bendazac makes it possible to perform therapeutic treatments with the oral route of administration as an agent with a normalizing effect on blood lipids.
    Type: Grant
    Filed: June 2, 1981
    Date of Patent: October 5, 1982
    Assignee: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
    Inventors: Bruno Silvestrini, Leandro Baiocchi
  • Patent number: 4350819
    Abstract: 1-Hydroxypyrazole and a process for its preparation by conversion of isoxazolineazoxy compounds at 140.degree.-600.degree. C.The end products obtainable by the process of the invention are valuable starting materials for the preparation of dyes, crop protection agents and drugs.
    Type: Grant
    Filed: July 17, 1981
    Date of Patent: September 21, 1982
    Assignee: BASF Aktiengesellschaft
    Inventors: Norbert Rieber, Heinrich Bohm, Rolf Platz, Werner Fuchs
  • Patent number: 4349560
    Abstract: The invention relates to imidazolyl-indenothiophene compounds of Formula (I) and a process for their production. Also included in the invention are antimycotic compositions containing said imidazolyl-indenothiophene compounds and methods for the use of said compounds and compositions.
    Type: Grant
    Filed: April 17, 1982
    Date of Patent: September 14, 1982
    Assignee: Bayer Aktiengesellschaft
    Inventors: Horst Boshagen, Karl H. Buchel, Wilfried Draber, Ingo Haller, Manfred Plempel
  • Patent number: 4348527
    Abstract: This disclosure describes novel 3-substituted amino-1-phenyl-2-pyrazolines and 3-substituted amino-1-mono and disubstituted phenyl-2-pyrazolines and their C.sub.4 and C.sub.5 analogs, effective as anti-inflammatory and analgesic agents, and as antibacterial agents and/or antifungal agents.
    Type: Grant
    Filed: July 13, 1981
    Date of Patent: September 7, 1982
    Assignee: American Cyanamid Company
    Inventors: John P. Dusza, Joseph P. Joseph, Seymour Bernstein
  • Patent number: 4348528
    Abstract: The invention relates to the preparation of 1-phenyl-3-carbamoyl-5-pyrazolones of the formula: ##STR1## in which the two symbols R and R' may be the same or different and each represents a hydrogen atom, an alkyl radical or a substituted alkyl radical containing 1 to 4 carbon atoms.An aqueous paste of diethyl oxalacetate phenylhydrazone is heated at a temperature not greater than 85.degree. C. until the hydrazone is completely melted, and the aqueous phase is then removed and the remaining hydrazone is treated with 2 to 12 molar equivalents of a compound of the formula HNRR' at a temperature between 20.degree. and 100.degree. C. The formation of 1-phenyl-3-carboxy-5-pyrazolone is thus avoided.
    Type: Grant
    Filed: July 13, 1981
    Date of Patent: September 7, 1982
    Assignee: P C U K Produits Chimiques Ugine Kuhlmann
    Inventors: Antoine G. L. J. Breda, Jacques G. R. Roussel
  • Patent number: 4343800
    Abstract: Compounds of the formula ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are hydrogen or substituents of various types;R.sub.4 is hydrogen; alkyl of 1 to 5 carbon atoms; or optionally substituted aralkyl of 7 to 14 carbon atoms;R.sub.5 is heterocycle;D is alkylene of 1 to 12 carbon atoms; andA is hydrogen or acyl;and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as .alpha.- and .beta.-adrenergic receptor blocking agents and antidepressants.
    Type: Grant
    Filed: April 20, 1981
    Date of Patent: August 10, 1982
    Assignee: Boehringer Ingelheim GmbH
    Inventors: Herbert Koppe, Anton Mentrup, Ernst-Otto Renth, Kurt Schromm, Wolfgang Hoefke, Gojko Muacevic
  • Patent number: 4338330
    Abstract: A derivative of benzimidazole of the general formula I: ##STR1## wherein: R.sub.1 represents a linear or ramified alkyl radical C.sub.1,C.sub.2,C.sub.3,C.sub.4,C.sub.5,C.sub.6,C.sub.7,C.sub.8,C.sub.9,C. sub.10,C.sub.11,C.sub.12,C.sub.13,C.sub.14,C.sub.15, C.sub.16,C.sub.17 or C.sub.18, a cycloalkyl radical C.sub.3,C.sub.4,C.sub.5,C.sub.6,C.sub.7 or C.sub.8, a linear or ramified alkyl radical C.sub.1,C.sub.2,C.sub.3,C.sub.4 or C.sub.5 substituted by one or more radicals selected from the group comprising:phenyl, phenoxy, phenylthio, phenylsufinyl radicals;phenyl, phenoxy, phenylthio, phenylsulfinyl radicals substituted by one or more linear or ramified alkyl radicals C.sub.1,C.sub.2, C.sub.3 or C.sub.4, by one or more linear or ramified alkoxy radicals C.sub.1,C.sub.2, C.sub.3 or C.sub.4, by a methylenedioxy radical, for one or more halogen atoms, such as fluorine, chlorine or bromine;linear or ramified alkylcarboxamido groups C.sub.1,C.sub.2,C.sub.3,C.sub.4,C.sub.5 or C.sub.
    Type: Grant
    Filed: April 30, 1980
    Date of Patent: July 6, 1982
    Assignee: Continental Pharma
    Inventors: Claude L. Gillet, Joseph L. Roba, Michel Snyers, William R. Van Dorsser, Georges E. Lambelin
  • Patent number: 4337263
    Abstract: 1-Aryl-4-.gamma.-arylsulphonyl-3-aminopropoxy-1H-pyrazoles of the formula: ##STR1## and their acid addition salts. Application of these compounds as medicaments useful in particular as hypolipemiant or hypocholesterolemiant agents.
    Type: Grant
    Filed: June 30, 1980
    Date of Patent: June 29, 1982
    Assignee: Laboratoire Roger Bellon
    Inventors: Henri Techer, Gilles Monnier, Marcel Pesson
  • Patent number: 4336385
    Abstract: Novel phosphate quaternary compound of the formula ##STR1## wherein R is a tertiary amine radical of from 6 to 40 carbon atoms; andX is an anion.
    Type: Grant
    Filed: April 4, 1980
    Date of Patent: June 22, 1982
    Assignee: Mona Industries, Inc.
    Inventors: Raymond L. Mayhew, Anthony J. O'Lenick, Jr.